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The goal of this study was to obtain at low temperature a functional nano-composite with 
characteristics similar to the natural bone by using a cost effective method. The structure 
and morphology of collagen coated zinc doped hydroxyapatite bio-composites (Zn:HAp-
CBc) were examined by X-Ray diffraction (XRD) and Scanning Electron Microscopy 
(SEM). XRD analysis revealed that the unique hexagonal Ca10(PO4)6(OH)2 in P63m space 
group was observed in the obtained nanocomposites Zn:HAp-CBc. The cytotoxicity of the 
Zn:HAp-CBc was studied on HeLa cell lines. Cell cycle distribution after treatment was 
examined by flow cytometry analysis. Our preliminary in vitro studies revealed that the 
obtained composites based on Zn doped HAp embedded in collagen matrix  have excellent 
biocompatibility and support their further characterization by in vivo approaches and 
development as a biomaterial used in bone regeneration. 
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1. Introduction 
 
According to a report prepared by the American Association of Orthopaedic Surgeons in 
2002, bone is the second most commonly transplanted material, surpassed only by blood 
transfusion. In order to repair severe bone injuries, caused mainly by congenital deformities, 
trauma, tumor resection or different degenerative diseases like osteomyelitis [1-2], bone grafts are 
required. In this context, the difficulty arises when choosing one of the three possible types of 
grafts. The first possibility is the use of an autograft. This involves harvesting a bone from the 
patient’s body in order to reimplant it. Although it is the most widely used grafting technique, the 
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amount of tissue that can be used is limited, and the additional surgery that the patient has to 
endure causes more pain and suffering without forgetting the increased risk of post-surgical 
infection [3]. Another possibility for bone grafting is the use of an allograft, which involves the 
harvest of bone tissue from an organ donor. Although this technique is less invasive than the first 
one, there is a higher risk of an infectious disease being transmitted from the donor to the patient 
[3]. Therefore, modern medicine has been focused on finding a better solution for the bone 
grafting problem. In this context, a third approach has emerged in the form of synthetic bone 
grafts. Thus, researchers worldwide have focused their attention on finding a material that can 
mimic the human bone tissue.   
The human bone is an extracellular matrix composed of two main parts: an inorganic part, 
where a major component is hydroxyapatite (HAp), with the chemical formula Ca10(PO4)6(OH)2, 
and an organic part consisting of collagen fibrils [4]. In this matrix the collagen fibers are aligned 
with the c-axes of the HAp nanocrystals [5]. Therefore, synthetic hydroxyapatite is a good 
candidate for bone regeneration due to the biocompatible and osteoconductive properties that it 
possesses [1]. It has already been used as bone filling or as coating on implanted medical devices 
such as orthopedic prostheses [1, 6]. In order to enhance certain properties of HAp, such as 
solubility, bioactivity and osteoinductivity, researchers have tried to include in its structure 
different ions through ionic substitutions [7-13]. A special attention has been paid to zinc (Zn) as a 
doping material. Zinc is the most commonly found trace metal in the bone mineral, stimulating 
bone formation in vivo and in vitro and inhibiting osteoclastic bone resorption in vivo [7,14]. 
Furthermore, recent studies have demonstrated that the incorporation of Zn into implants speeds 
the bone formation process around the material [15-17]. 
Given the fact that synthetic hydroxyapatite can mimic the composition of natural bone, 
and zinc doped hydroxyapatite enhances the properties that HAp exhibits, in order to create a 
better biomaterial that could minimize the risk of triggering a defensive response from the host 
tissue, the structure of the natural bone must also be mimicked. This can be achieved by including 
in the synthetic composite the characteristics of the organic part of the human bone matrix. 89% of 
the bone organic matrix is comprised of collagen [3, 18]. Collagen is a natural polymer that can be 
found in various tissues such as skin and bone (Type I), cartilage (Type II) and blood vessel walls 
(Type III) [1].  It has been used in tissue engineering and repair due to its outstanding 
biocompatibility, being easily resorbed by the human body and allowing a good attachment to cells 
[1,19-22]. Recent studies have proven that collagen and hydroxyapatite devices inhibit the growth 
of bacterial pathogens, thus minimizing the risk of post-surgical infections occurring after 
implanting prostheses [1, 23].  
The increasing need for new biomaterials with enhanced properties has determined 
researchers worldwide to try to mimic the characteristics of the natural human tissues. Given the 
fact that the bone tissue is a complex system, its synthetic replication has to take into account 
many variables. By combining many composites naturally found in the human hard tissue we hope 
to create a material that could be integrated in the living human body without triggering any 
adverse effects, thus improving the quality of life of the patients who had undergone major 
orthopedic surgeries. 
The present study focuses on the synthesis and characterization of novel of zinc doped 
hydroxyapatite in collagen matrix. The X-Ray diffraction (XRD) and Scanning Electron 
Microscopy (SEM) were used to investigate the structural and morphological properties of doped 
hydroxyapatite bio-composite (Zn:HAp-CBc). The cytotoxic effect of Zn:HAp-CBc on HeLa 
human cancer cell line  was also evaluated in this study. 
 
 
2. Materials and Methods  
 
2.1 Materials     
In order to synthesize the zinc doped hydroxyapatite (Zn:HAp), precursors of calcium 
nitrate [Ca(NO3)2∙4H2O, Aldrich, USA], ammonium hydrogen phosphate ((NH4)2HPO4; Wako 
Pure Chemical Industries Ltd.) and zinc nitrate hexahydrate (Zn(NO3)6.6H2O, Alpha Aesare, 
Germany, 99.99 % purity) were used. Type I fibrillar collagen in gel form (Coll) with a 
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concentration of 2.11% (w/w) was extracted from calf hide by acid and alkaline treatments as 
previously described [24]. Glutaraldehyde was purchased from Merck (Germany). Sodium 
hydroxide and phosphate buffer solution (PBS), pH 7.4 were of analytical grade. 
 
2.2 Zinc doped hydroxyapatite (Zn:HAp) nanoparticles  
Controlled amounts of ammonium hydrogen phosphate and zinc nitrate were dissolved in 
ethanol. After adding distilled water, the solution was stirred vigorously for 24 h at 40 
°
C. In a 
separate container, a stoichiometric amount of calcium nitrate was dissolved in ethanol with 
vigorous stirring for 24 h at 40
°
C. The Ca-containing solution was added slowly to the P-
containing solution, and then aged at room temperature for 72 h and further at 40 
°
C for 24 h. The 
composition ratios in the Zn:HAp (xZn=0.1) sol were adjusted to have [Ca+Zn]/P as 1.67 [25-27]. 
The obtained Zn:HAp nanopowders were treated at 80 
°
C for 6 hours. 
 
2.2.1 Collagen coated zinc doped hydroxyapatite bio-composites (Zn:HAp-CBc) 
preparation 
Zinc doped hydroxyapatite was added to collagen gel and Zn:HAp-CBc with the following 
ratios: 0:1 (collagen reference), 4:1 (Zn:HAp-CBc_4), 1:1 (Zn:HAp-CBc_1) and 1:0 (Zn:HAp 
reference) were obtained.  All the gel composites had the same collagen concentration, 1.2% 
(reported to dry substance), pH 7.4 and they were cross-linked with 0.5% GA according to the 
method previously described [28]. After cross-linking process the gel composites were lyophilized 
using the Christ Model Delta 2–24 LSC freeze-dryer (Germany) and 3D porous composites were 
obtained. 
 
2.3 Sample characterization 
X-ray diffraction measurements have been obtained using a Bruker D8 Advance 
diffractometer, with nickel filtered CuK𝛼 (𝜆 = 1.5418 Å) radiation and a high efficiency one 
dimensional detector (Lynx Eye type) operated in integration mode. The measurement parameters 
have been the 2𝜃 range 15∘–140∘, step of 0.02∘ and 34 s measuring time per step. Scanning electron 
microscopy (SEM) has been used to show the morphology of all the samples using a HITACHI 
S2600N-type microscope equipped with an energy dispersive X-ray attachment (EDAX/2001 
device). The secondary device was useful for the identification of the elemental composition. 
Moreover the Raman spectra have been recorded. Raman spectra were measured with a micro-
Raman spectrometer (in Via, Renishaw, Inc.) in a backscattering geometry using a 50 objective 
lens. An excitation wavelength at 514 nm emitted by an Ar-ion 10 mW monochromatic laser 
source and a 1800 lines/mm grating were used for the acquisition of the Raman spectra. Beam 
centering and Raman spectra calibration were performed before each acquisition using a Si 
standard with a characteristics peak at 520.3 cm
-1
. Raman analyses were recorded and treated with 
Wire 3.3 software.  
 
2.4 Cytotoxicity Assay 
HeLa cells were used in our experiments. The cells were cultivated in DMEM:F12 
(Invitrogen, NY, SUA) supplemented with 10% heat-inactivated bovine serum and 
penicillin/streptomycin at 37°C with 5% CO2. The cell morphology was observed by fluorescence 
microscopy. Briefly, the cells were fixed in 70% ethanol, colored with 5µg/ml propidium iodide 
and observed with a Leica DFC450 microscope.  
The cytotoxicity was established using Trypan blue staining after the treatment with 
100µg/ml compound for 24h. Summarily, after the treatment period, cells were harvested from the 
substrate and 50 µl of each cellular suspension was mixed to a freshly prepared solution of 50 µl 
Trypan blue (0.05% in distilled water). The mixed suspension was spread onto a microscope slide, 
covered with a coverslip and observed by microscopic examination. Nonviable cells appear blue-
stained. At least 200 cells were counted per treatment.  
 
2.5 Cell cycle distribution 
3 x 10
5
 cells were plated in each well of 6 well plates and treated for 72 hour with 100 
µg/ml material. After the treatment period, cells were taken from the substrate,  fixed in 70% cold 
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ethanol over night at -20
0
C, washed twice in PBS, and then incubated 15 min, at 37
0
C, with 
RNAse A (1 mg/mL), and 1 h with propidium iodide (100 µg/mL). After staining the cells with 
propidium iodide, the acquisition was done using an Epics Beckman Coulter flow cytometer. Data 
were analysed using Flow Jo software and expressed as fractions of cells in the different cycle 
phases.  
 
 
3. Results and discussions 
 
The X-ray diffraction spectra of Zn:HAp and Zn:HAp-CBc (Zn:HAp-CBc_1 and Zn:HAp-
CBc_4) are shown in Fig. 1. All the diffraction peaks of pure hexagonal HAp (ICCD-PDF#9-432) 
are detected from the patterns obtained for the Zn:HAp and Zn:HAp-CBc (Zn:HAp-CBc_1 and 
Zn:HAp-CBc_4) samples. Compared to the Zn:HAp nanoparticles, the  broadening of the 
diffraction peaks of Zn:HAp-CBc shows  a decrease in intensity which implies  a small grain size 
and low crystallinity [29]. Furthermore, it can be seen that the peak intensities decrease when the 
ratio collagen/Zn:HAp (Zn:HAp-CBc_1) increases.  
 
Fig. 1 X-ray diffraction patterns of Zn:HAp, Zn:HAp-CBc_4 and Zn:HAp-CBc_1 
 
 
In order to investigate the morphology and the porosity of collagen coated zinc doped 
hydroxyapatite bio-composites (Zn:HAp-CBc), scanning electron microscopy images were 
recorded. Fig. 2 shows the SEM image of collagen (Fig. 2a), Zn:HAp (Fig. 2b) and Zn:HAp-CBc 
(Fig. 2c-d). The structure of collagen is presented in Fig. 2a while the ellipsoidal particles at 
nanometric scale of Zn:HAp were observed in the SEM image Fig. 2b. In Fig. 2c-d can be seen 
that composite materials have become porous when the ratio Zn:HAp/collagen decreases 
(Zn:HAp-CBc_1).  
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Fig. 2 SEM images of collagen (a), Zn:HAp (b), Zn:HAp-CBc_4 (c), Zn:HAp-CBc_1 (d) 
 
 
The porosity of composite materials is seen to be directly proportional to the amount of 
collagen in the samples (Zn:HAp-CBc_1 > Zn:HAp-CBc_4). A good homogeneity was also 
observed in the samples. Increasing the Zn:HAp content, the ellipsoidal shape of nanocomposite 
are much visible. The nanoparticles of Zn:HAp are incorporated into a fibrillar network structure 
of collagen in both samples (Zn:HAp-CBc_1 and Zn:HAp-CBc_4) and  the SEM images provide 
direct evidence. A good homogeneity was also observed in the samples.  
The EDX spectrum and mapping of collagen bioceramic material (Zn:HAp-CBc_1) are 
presented in Fig. 3. EDX spectrum and of Zn:HAp-CBc showed that the main elements present in 
the sample are calcium, phosphor, zinc, oxygen and carbon. On the other hand, a uniform 
distribution of constituent elements was observed. These results suggested that Zn:HAp 
nanoparticles were successfully incorporated in collagen matrix. 
 
 
Fig. 3 EDX spectrum and mapping of collagen bioceramic material (Zn:HAp-CBc_1) 
 
 
The Raman spectra were recorded with a micro-Raman spectrometer (inVia, Renishaw, 
Inc.) in backscattering geometry. The excitation wavelength used was 514 nm emitted by an Ar-
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ion 10 mW monochromatic laser source. The Raman spectra of the Collagen, Zn:HAp (xZn=0.1), 
Zn:HAp-CBc_1 and Zn:HAp-CBc_4 are presented in Fig. 4. 
In the Raman spectrum of collagen, the most important vibrational bands which are 
highlighted in Fig. 4 are attributed to: ν amide I (1600-1700 cm-1), ν C-H bending (1400-1500 cm-
1), ν amide III (1200-1300 cm-1), ν C-C skeletal (900-1000 cm-1) and ν C-C ring (800-900 cm-1), 
respectively [30-32]. For the Zn:HAp (xZn=0.1) sample, the Raman spectrum  (Fig. 4) exhibits the 
main vibrational bands characteristic to the apatite structure. Furthermore, in the spectra recorded 
for the Zn:HAp-CBc_1 and Zn:HAp-CBc_4 samples, the vibrational bands for the collagen and 
apatitic structure could be observed. The dominant band (962 cm
-1
) in the Raman spectra is 
attributed to the ν1 PO4
3-
 internal mode. The other bands are associated with the ν2 and ν4 phosphate 
groups vibrations and are observed at: 430 cm
-1
, 445 cm
-1
 (ν2 PO4
3-
) and 582 cm
-1
, 591 cm
-1
, 607 
cm
-1
 (ν4 PO4
3-
). 
 
Fig. 4 Raman spectra of the Zn:HAp (xZn=0.1), Zn:HAp-CBc_1, Zn:HAp-CBc_4 and Collagen 
 
 
The vibrational band observed at 1047 cm
-1
 is attributed to the ν3 PO4
3-
 vibration mode 
[33, 25]. The assignment of the main bands is summarized in Table 1.  
 
 
Table 1: Raman bands and their associated vibrational modes. 
 
Wavenumber (cm
-1
) 
Zn:HAp (xZn=0.1) Zn:HAp-CBC_1 Zn:HAp-CBC_4 Vibrational modes 
432 
445 
582 
591 
607 
962 
1047 
- 
- 
- 
- 
430 
447 
- 
590 
610 
960 
1047 
1070 
1266 
1451 
1664 
430 
444 
581 
590 
607 
960 
1046 
1072 
1245 
1451 
1664 
ν2 PO4
3-
 
ν2 PO4
3-
 
ν4 PO4
3-
 
ν4 PO4
3-
 
ν4 PO4
3- 
ν1 PO4
3- 
ν3 PO4
3-
 
ν3  PO4
3-
 
ν Amide III 
ν C-H bending 
ν Amide I 
 
 
The bands associated with the presence of collagen show an increase in intensity, while 
the bands associated with the apatitic structure show an intensity decrease, becoming wider when 
the collagen concentration increases. 
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The TGA and DTA curves behavior of collagen, Zn:HAp-CBc_1, Zn:HAp-CBc_4 and 
Zn:HAp nanoparticles  are illustrated in Fig. 5. The TGA and DTA curves of these samples were 
performed in the presence of static air at a linear heating rate of 10
o
C/min from 30
o
C to 800
o
C. 
The TGA curve of Zn:HAp (xZn = 0.1) does not show a sharp weight loss or a steep slope between 
30-800
o
C. This behavior demonstrates that the decomposition of Zn:HAp does not occur before 
800
o
C. The total weight loss of the Zn:HAp (xZn = 0.1) nanoparticles is 3.43%. On the one hand, 
this loss may be associated to the evaporation of adsorbed and structurally incorporated water and 
removal of residual solvent, on the other hand.  According to S. Cameron et al.  [34] the adsorbed 
water was removed from the surface at temperatures greater than 200
o
C and from pores up to 
500
o
C while the structurally incorporated water was removed at temperatures above 900
o
C.  
The TGA curve of collagen shows one weight loss of 13.7% from 30
o
C to around 220
o
C 
and another two weight losses of 49.13% from 210
o
C to 490
o
C and 35.17% from 490
o
C to 570
o
C. 
After 570
o
C the total weight loss remains constant at 98%. These values are in good agreement 
with those presented by M. Tegza et al. [35] in previous studies. According to M. Tegza et al. [35] 
the minimal mass loss in the first range of temperature is due to the dehydration process, while the 
second mass loss is due to processes of thermal and oxidative destruction characterized by a more 
rapid decomposition.  The third mass loss which occurs in the temperature range from 490
o
C to 
570
o
C is due to destruction accompanied by burning out of the coke residue. 
The influence of collagen is observed in TGA curves of Zn:HAp-CBc_1 and Zn:HAp-
CBc_4 nanoparticles. The total mass loss increases when the amount of collagen in the sample is 
greater (Zn:HAp-CBc_1). The Zn:HAp-CBc_1 nanoparticles showed a mass loss of 9.7 % in the 
temperature range from 30
o
C to 287
o
C, while the mass loss in the temperature range from 287
o
C to 
620
o
C is  about 10%. The total mass loss in the Zn:HAp-CBc_1 nanoparticles was around 20.18% 
at 620
o
C. Above 620
o
C no significant weight loss was observed. When the collagen decreased in 
the sample (Zn:HAp-CBc_4), the TGA curve shows two marked weight losses. The first mass loss 
of 7% in the temperature range from 30
o
C to 270
o
C. The second weight loss is 5.87% in the 
temperature range from 270
o
C to 610
o
C. Zn:HAp-CBc_4 nanoparticles showed a  total weight loss 
of  12.87% at 610
o
C.  On the other hand, it can be seen that the total weight loss after 620
o
C 
remains fairly constant at 12.87%. The thermo-gravimetric analysis (TGA) of the Zn:HAp-CBc 
showed a  decrease in the weight loss with increasing the amount of Zn:HAp nanoparticles 
(Zn:HAp-CBc_4). 
The differential thermal analysis (DTA) curve of the Zn:HAp nanoparticles shows an 
endothermic peak at around 55
o
C followed by a broad exothermic peak centered at about 300
o
C. 
The endothermic peak below 200
o
C is due to desorption of adsorbed water and possible 
elimination of crystal lattice water [36-38]. In agreement with previous studies [39] we can say 
that the broad exothermic peak centered at 300
o
C indicates the crystallization of ZnHAp.  
In the collagen DTA curve a three stage degradation is observed. The DTA curve of 
collagen shows significant degradation occurred at 176
o
C, 330
o
C and 560
o
C. According to 
previous studies [40] the exothermic peak at 176
o
C is due to loss of water molecules bound to the 
surface, the exothermic peak at 330
o
C is due to fragmentation of the macromolecule, while at 
560
o
C the major decomposition occurred due to the formation of gaseous elements. The first 
endothermic peaks in differential thermal analysis (DTA) curves of the Zn:HAp-CBc_4 and 
Zn:HAp-CBc_1 at around 60
o
C and 58
o
C respectively are considered to be the result of desorption 
of adsorbed water. The first endothermic peak is followed by an exothermic peak in the DTA 
curve at 323
o
C (Zn:HAp-CBc_4) and  327
o
C (Zn:HAp-CBc_1) indicates the crystallization of 
Zn:HAp-CBc samples [39]. 
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Fig. 5 The TGA and DTA curves behavior of collagen, Zn:HAp-CBc_6, Zn:HAp-CBc_18 and Zn:HAp 
nanoparticles 
 
 
Fig. 6 shows that the cells cultivated in the presence of the obtained composites have 
morphology similar to that of the control, i.e. polygonal cells, homogenously distributed on the 
surface.   
 
Fig. 6 Morphological studies of HeLa cells (control) following exposure to Collagen, 
Zn:HAp-CBc_1, Zn:HAp-CBc_4 and Zn:HAp (xZn=0.1) nanoparticles (10 mg/ml) for 72 h 
after treatment observed under  optic  microscopy.  Each  experiment  was  performed  in  
triplicate 
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The influence of the obtained composites on the cellular cycle  of HeLa cells was detected 
further using flow cytometry, with Annexin V-FITC/propidium iodide double-staining of cells. 
When the HeLa cells were treated with Collagen, Zn:HAp-CBc_1, Zn:HAp-CBc_4 and Zn:HAp 
no significant changes were found, suggesting  that there was no significant difference between the 
obtained composites and the raw materials with regard to cell proliferation and apoptosis (Fig. 7) 
 
 
 
Fig. 7 Cell cycle analysis of HeLa cells cultured with 0.1% DMSO (Control) and treated  
with Collagen, Zn:HAp-CBc_1, Zn:HAp-CBc_4 and Zn:HAp (xZn=0.1) 
 
 
According to previous studies [7, 22-23, 38-43] hydroxyapatite has a high affinity for 
different species of metal ions. Based on the fact that zinc is the most commonly found trace metal 
in the mineral phase of the bone, the goal of this work was to study the substitution in the structure 
of hydroxyapatite coated with collagen of calcium by zinc ions. The results of our studies on 
cytotoxic effect of Zn:HAp-CBc on HeLa human cancer cell line show a homogenous distribution 
on the surface with a morphology similar to that of the control (Fig. 6).  On the other hand, cell 
cycle analysis of HeLa cells cultured with 0.1% DMSO (Control) and treated with Collagen, 
Zn:HAp-CBc_1, Zn:HAp-CBc_4 and Zn:HAp (xZn = 0.1)  showed no differences between the 
obtained composites and the raw materials with regard to cell proliferation and apoptosis (Fig. 7). 
Moreover, it is very clear that the substitution of calcium by zinc ions in the structure of 
hydroxyapatite coated with collagen does not affect the general crystal structure (Fig. 1). 
The results of this study show that the Zn:HAp-CBc samples with controlled particle size can be 
obtained  by co-precipitation method. The collagen and zinc concentrations play an important role 
in the particle size and the morphology of the particles. EDX analysis (Fig. 3) gives the 
information regarding the composition of the Zn:HAp-CBc composite materials. It was observed 
that the constituent elements, C, P, O, Ca and Zn, were uniformly distributed. Additionally, the 
Raman spectra (Fig. 4) of Zn:HAp-CBc composite materials show the peaks associated to 
phosphate and carbonate groups and the specific peaks in the region 500-750 cm
-1
 and at 1548 and 
1659 cm
-1
  attributed to Amide IV-VII and Amide II, respectively.  Based on XRD, SEM, EDAX 
and in vitro results, it was concluded that the Zn:HAp-CBc composite materials could be a viable 
candidate for future development of bone implants. 
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4. Conclusions 
 
The present study presents a method for obtaining a novel bio-composite based on zinc 
doped hydroxyapatite in collagen matrix. The XRD studies have confirmed that hydroxyapatite 
was formed and the final material was crystallized. Raman investigations of the bio-composite 
based on zinc doped hydroxyapatite in collagen matrix showed specific absorption bands 
associated to hydroxyl and phosphate groups characteristic to the hydroxyapatite structure. The 
mapping studies have evidenced an uniform distribution of the constituent elements.  
Our in vitro preliminary studies reveal that the obtained composites based on Zn doped 
HAp embedded in collagen matrix  has excellent biocompatibility and support its further 
characterization by in vivo approaches and development as a biomaterial used in bone 
regeneration. 
One of the ultimate goals of engineered biomedicine is to create new materials able to 
replace damaged natural tissues. The natural hard tissue is a very complex system that has specific 
properties and functions. In order to replicate this part of the human body, the characteristic of 
bones must be replicated. Therefore, the synthetic materials used for the reconstruction of bone 
injuries must mimic the natural components found in the bone tissue. The aim of our research was 
to study the combination of various synthetic materials in order to improve the quality of the 
implants. Given the promising results obtained for the Zn:HAp-CBc composite materials, we 
could say that the novel bio-composite of zinc doped hydroxyapatite in collagen matrix is a cost 
efficient biomaterial that can be used in biological applications as a bone replacement material. 
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